| JNJ-40411813 |
JNJ40411813 |
1127498-03-6 |
| IWR-1-endo |
IWR-1 |
1127442-82-3 |
| SR-3306 |
化合物SR-3306 |
1128096-91-2 |
| IM-12 |
IM-12 |
1129669-05-1 |
| GSK1838705A |
GSK1838705A |
1116235-97-2 |
| TAK-593 |
1005780-62-0 |
1005780-62-0 |
| Dacomitinib (PF299804) |
达克替尼 |
1110813-31-4 |
| BenzeneacetaMide, N-[(1S)-2-[(6,7-dihydro-5-Methyl-6-oxo-5H-dibenz[b,d]azepin-7-yl)aMino]-1-Methyl-2-oxoethyl]-3,5-difluoro-α-hydroxy-,(αS)- |
(2S)-2 - ((S)-2-(3,5-二氟苯基)-2-羟基乙酰基)-N-(5-甲基-6-氧代-6 |
1103722-91-3 |
| D-xylo-Pentodialdo-5,2-furanose, 1-C-[4-chloro-3-[(4-ethoxyphenyl)Methyl]phenyl]-4,5-O-(1-Methylethylidene)-,(5S)- |
LX4211 N-4中间体 |
1103738-30-2 |
| D-xylo-Pentodialdo-5,2-furanose, 4,5-O-(1-Methylethylidene)-1-C-4-Morpholinyl-,(5S)- |
(5S)-4,5-O-(1-甲基亚乙基)-1-C-4-吗啉基-D-戊二醛-5,2-呋喃木糖 |
1103738-19-7 |
| 2,6-Difluoro-3-(propylsulfonaMido)benzoic acid |
唯罗菲妮中间体 |
1103234-56-5 |
| Butanedioic acid, 2,3-bis[(4-Methylbenzoyl)oxy]-, (2R,3R)-, coMpd. with (1R,2R)-2-[(phenylMethyl)aMino]cyclohexanol (1:2) |
(1R,2R)-2-(苄基氨基)环己醇(2R,3R)-2,3-双((4-甲基苯甲酰基)氧基)琥珀酸酯 |
1106691-66-0 |
| 3-Azetidineacetic acid, 3-aMino-1-[(1,1-diMethylethoxy)carbonyl]-, Methyl ester |
3-氨基-3-(2-甲氧基-2-氧代乙基)氮杂环丁烷-1-羧酸叔丁酯 |
1105662-89-2 |
| 2,5-Diazaspiro[3.5]nonane-2-carboxylic acid, 6,8-dioxo-, 1,1-diMethylethyl ester |
6,8-二氧代-2,5-二氮杂螺[3.5]壬烷-2-羧酸叔丁酯 |
1105662-95-0 |
| Tepotinib |
特泊替尼 |
1100598-32-0 |
| N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine |
ASP3026 |
1097917-15-1 |
| 4-PyriMidinecarboxylic acid, 6-aMino-5-chloro-, ethyl ester |
6-氨基-5-氯-4-嘧啶甲酸乙酯 |
1097250-86-6 |
| BenzenesulfonaMide, N,N'-[1,2-ethanediylbis[oxy[5-(2-Methoxyphenoxy)[2,2'-bipyriMidine]-6,4-diyl]]]bis[4-(1,1-diMethylethyl)- |
波生坦USP相关物质C |
1097263-60-9 |
| ethyl 5,6-dichloropyriMidine-4-carboxylate |
5,6-二氯-4-嘧啶甲酸乙酯 |
1097250-57-1 |
| AMG-208 |
AMG 208 |
1002304-34-8 |
